SG Americas Securities’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,421
| Closed | -$12K | – | 2898 |
|
|
2025
Q1 | $12K | Sell |
1,421
-3,071
| -68% | -$25.9K | ﹤0.01% | 2976 |
|
|
2024
Q4 | $161K | Buy |
4,492
+1,003
| +29% | +$35.9K | ﹤0.01% | 2085 |
|
|
2024
Q3 | $165K | Sell |
3,489
-2,060
| -37% | -$97.4K | ﹤0.01% | 2348 |
|
|
2024
Q2 | $279K | Buy |
5,549
+4,208
| +314% | +$212K | ﹤0.01% | 1795 |
|
|
2024
Q1 | $150K | Sell |
1,341
-228
| -15% | -$25.5K | ﹤0.01% | 1964 |
|
|
2023
Q4 | $91K | Sell |
1,569
-297
| -16% | -$17.2K | ﹤0.01% | 2554 |
|
|
2023
Q3 | $59K | Buy |
+1,866
| New | +$59K | ﹤0.01% | 2613 |
|
|
2023
Q2 | – | Sell |
-1,864
| Closed | -$192K | – | 2487 |
|
|
2023
Q1 | $192K | Sell |
1,864
-93
| -5% | -$9.58K | ﹤0.01% | 2224 |
|
|
2022
Q4 | $287K | Buy |
1,957
+373
| +24% | +$54.7K | ﹤0.01% | 1754 |
|
|
2022
Q3 | $268K | Sell |
1,584
-318
| -17% | -$53.8K | ﹤0.01% | 1859 |
|
|
2022
Q2 | $220K | Buy |
+1,902
| New | +$220K | ﹤0.01% | 2369 |
|
|
2022
Q1 | – | Sell |
-651
| Closed | -$101K | – | 2836 |
|
|
2021
Q4 | $101K | Sell |
651
-818
| -56% | -$127K | ﹤0.01% | 2782 |
|
|
2021
Q3 | $346K | Buy |
+1,469
| New | +$346K | ﹤0.01% | 2584 |
|
|
2021
Q2 | – | Sell |
-500
| Closed | -$202K | – | 2720 |
|
|
2021
Q1 | $202K | Buy |
500
+229
| +85% | +$92.5K | ﹤0.01% | 2438 |
|
|
2020
Q4 | $180K | Sell |
271
-1,133
| -81% | -$753K | ﹤0.01% | 2365 |
|
|
2020
Q3 | $654K | Buy |
1,404
+726
| +107% | +$338K | ﹤0.01% | 1212 |
|
|
2020
Q2 | $397K | Buy |
678
+162
| +31% | +$94.9K | ﹤0.01% | 1959 |
|
|
2020
Q1 | $75K | Buy |
+516
| New | +$75K | ﹤0.01% | 2618 |
|